CLEC2D and neoplasm: Taken together, our findings indicate that 4KO-LLT1 CAR-T cells exhibit effective and specific cytotoxicity against CD38+ tumor cells, with HLA knockdown promoting CAR-T cell proliferation and LLT1 overexpression enhancing their cytotoxicity.